Genetix licenses reagent for genetic mutations:
This article was originally published in Clinica
Executive Summary
UK company Genetix Group has licensed a DNA-based reagent, to detect genetic mutations linked to hereditary diseases, from the University of Nottingham. The New Milton, Hampshire company plans to manufacture and market the reagent as part of its consumables range. It can be used with Genetix' automated systems. It will allow clinical researchers to determine more effectively the nature of mutations in conditions such as breast cancer.